- Home
- LPTX vs LMFA Comparison
LPTX vs LMFA Comparison
Compare LPTX & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- LMFA
- Stock Information
- Founded
- LPTX 2011
- LMFA 2008
- Country
- LPTX United States
- LMFA United States
- Employees
- LPTX N/A
- LMFA N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- LMFA Finance: Consumer Services
- Sector
- LPTX Health Care
- LMFA Finance
- Exchange
- LPTX Nasdaq
- LMFA Nasdaq
- Market Cap
- LPTX 11.1M
- LMFA 11.9M
- IPO Year
- LPTX N/A
- LMFA 2015
- Fundamental
- Price
- LPTX $0.31
- LMFA $1.25
- Analyst Decision
- LPTX Hold
- LMFA Strong Buy
- Analyst Count
- LPTX 1
- LMFA 1
- Target Price
- LPTX N/A
- LMFA $5.00
- AVG Volume (30 Days)
- LPTX 710.1K
- LMFA 512.2K
- Earning Date
- LPTX 11-12-2025
- LMFA 11-12-2025
- Dividend Yield
- LPTX N/A
- LMFA N/A
- EPS Growth
- LPTX N/A
- LMFA N/A
- EPS
- LPTX N/A
- LMFA N/A
- Revenue
- LPTX N/A
- LMFA $6,755,925.00
- Revenue This Year
- LPTX N/A
- LMFA N/A
- Revenue Next Year
- LPTX N/A
- LMFA $6.50
- P/E Ratio
- LPTX N/A
- LMFA N/A
- Revenue Growth
- LPTX N/A
- LMFA N/A
- 52 Week Low
- LPTX $0.22
- LMFA $1.02
- 52 Week High
- LPTX $4.79
- LMFA $5.14
- Technical
- Relative Strength Index (RSI)
- LPTX 53.90
- LMFA 40.94
- Support Level
- LPTX $0.28
- LMFA $1.17
- Resistance Level
- LPTX $0.32
- LMFA $1.30
- Average True Range (ATR)
- LPTX 0.02
- LMFA 0.09
- MACD
- LPTX 0.00
- LMFA 0.05
- Stochastic Oscillator
- LPTX 73.33
- LMFA 79.25
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.